Role of the RhoGEF Net1 in breast cancer cell motility and metastasis
RhoGEF Net1 在乳腺癌细胞运动和转移中的作用
基本信息
- 批准号:8697496
- 负责人:
- 金额:$ 31.54万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-04-01 至 2019-02-28
- 项目状态:已结题
- 来源:
- 关键词:AcetylationActomyosinAddressAffectAutomobile DrivingBiological AssayBreast Cancer CellBreast Cancer TreatmentCell NucleusCell ProliferationCell membraneCellsCytoskeletal GeneCytoskeletal ModelingDataDeacetylaseDefectDevelopmentDiseaseEGF geneERBB2 geneEpidermal Growth Factor ReceptorExtracellular MatrixFocal AdhesionsGTP-Binding ProteinsGene ExpressionGenesGeneticGrowth Factor ReceptorsGuanine Nucleotide Exchange FactorsHDAC6 geneHistone DeacetylaseHumanIn VitroIntegrinsInterventionKnockout MiceLigandsMMP14 geneMalignant NeoplasmsMammary NeoplasmsMammary glandMediator of activation proteinMesenchymalMetastatic toMitoticMolecularMovementMusMutationNeoplasm MetastasisNeuroepithelialNodalOncogenesOncogenicPTK2 genePhosphorylationProcessProtein FamilyProtein IsoformsProteinsReceptor ActivationRoleSignal TransductionSiteTubulinUnited StatesWomanWorkameboid movementbasecancer cellcell motilitycell transformationin vivokillingsmalignant breast neoplasmmammary gland developmentnew therapeutic targetnovelnovel therapeuticsoverexpressionpreventpublic health relevancerhorho GTP-Binding Proteinstumorigenesis
项目摘要
DESCRIPTION (provided by applicant): Molecular mechanisms controlling metastasis in breast cancer are not well understood. During invasion of the extracellular matrix (ECM) cancer cells alternate between fast, amoeboid, and slow mesenchymal types of movement. This plasticity in movement is essential for efficient invasion, but it is not well understood how it is
controlled. We have found that the RhoGEF Net1A is an important regulator of invasion plasticity in breast cancer cells, stimulating amoeboid and suppressing mesenchymal movement. Net1A regulates this process by controlling RhoA and deacetylase function to impact cytoskeletal organization and gene expression. Net1A is exceptional among RhoGEFs in that it is sequestered in the nucleus to prevent aberrant RhoA activation, and it is clear that subcellular localization is a key determinant of the oncogenic potential of Net1 isoforms. Recently we have shown that Rac1 activation downstream of integrin or growth factor receptor activation stimulates Net1A relocalization to the plasma membrane. We have also found that Net1A relocalization is maintained by site-specific acetylation, and that the actions of specific deacetylases are critical to suppressing Net1A activity towards RhoA. Moreover, we have observed that Net1A reciprocally controls the activity of specific deacetylases to regulate cytoskeletal organization and expression of key genes associated with cell invasion, such as MT1-MMP. These findings support our hypothesis that that Net1A functions as a nodal point to temporally and spatially regulate RhoA activation and deacetylase activity which underlie breast cancer cell motility, invasion and metastasis. In this proposal we will use a combination of cell-based and in vivo assays to understand how Net1A localization is regulated to drive RhoA activation and reciprocally control deacetylase activity during ECM invasion. We will also determine how Net1 isoforms contribute to mammary gland tumorigenesis and metastasis in vivo. In Aim 1 we will demonstrate how EGFR and HER2 activation stimulates Net1A export from the nucleus to stimulate cell motility and ECM invasion. We will demonstrate how Net1A acetylation affects its function and identify the deacetylases that regulate Net1A. In Aim 2 we will determine how Net1A controls HDAC and Sirtuin function to regulate acetylation of cytoskeletal organizing proteins and gene expression. In Aim 3 we will identify the molecular basis for how genetic deletion of Net1 affects mammary gland development in mice, and determine whether Net1 is required for HER2/Neu driven mammary gland tumorigenesis and metastasis. Completion of these aims will provide a mechanistic understanding of how Net1 isoforms contribute to breast cancer cell motility and invasive potential, and will provide novel targets for intervention in metastatic disease.
描述(申请人提供):控制乳腺癌转移的分子机制尚不清楚。在侵袭细胞外基质(ECM)期间,癌细胞在快速、变形虫和缓慢的间充质类型运动之间交替进行。这种运动的可塑性对于有效的入侵是必不可少的,但它是如何被很好地理解的
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jeffrey A. Frost其他文献
Jeffrey A. Frost的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jeffrey A. Frost', 18)}}的其他基金
Rho GEFs in Cellular Proliferation and Transformation
Rho GEF 在细胞增殖和转化中的作用
- 批准号:
8054869 - 财政年份:2007
- 资助金额:
$ 31.54万 - 项目类别:
Rho GEFs in Cellular Proliferation and Transformation
Rho GEF 在细胞增殖和转化中的作用
- 批准号:
7616460 - 财政年份:2007
- 资助金额:
$ 31.54万 - 项目类别:
Rho GEFs in Cellular Proliferation and Transformation
Rho GEF 在细胞增殖和转化中的作用
- 批准号:
7805539 - 财政年份:2007
- 资助金额:
$ 31.54万 - 项目类别:
Rho GEFs in Cellular Proliferation and Transformation
Rho GEF 在细胞增殖和转化中的作用
- 批准号:
7425445 - 财政年份:2007
- 资助金额:
$ 31.54万 - 项目类别:
Rho GEFs in Cellular Proliferation and Transformation
Rho GEF 在细胞增殖和转化中的作用
- 批准号:
8244651 - 财政年份:2007
- 资助金额:
$ 31.54万 - 项目类别:
Rho GEFs in Cellular Proliferation and Transformation
Rho GEF 在细胞增殖和转化中的作用
- 批准号:
7210953 - 财政年份:2007
- 资助金额:
$ 31.54万 - 项目类别:
Rho GEFs in Cellular Proliferation and Transformation
Rho GEF 在细胞增殖和转化中的作用
- 批准号:
8137506 - 财政年份:2007
- 资助金额:
$ 31.54万 - 项目类别:
相似国自然基金
由actomyosin介导的集体性细胞迁移对唇腭裂发生的影响的研究
- 批准号:82360313
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
Nuclear force feedback as rheostat for actomyosin tension control
核力反馈作为肌动球蛋白张力控制的变阻器
- 批准号:
MR/Y001125/1 - 财政年份:2024
- 资助金额:
$ 31.54万 - 项目类别:
Research Grant
CAREER: Cytokinesis without an actomyosin ring and its coordination with organelle division
职业:没有肌动球蛋白环的细胞分裂及其与细胞器分裂的协调
- 批准号:
2337141 - 财政年份:2024
- 资助金额:
$ 31.54万 - 项目类别:
Continuing Grant
CAREER: Computational and Theoretical Investigation of Actomyosin Contraction Systems
职业:肌动球蛋白收缩系统的计算和理论研究
- 批准号:
2340865 - 财政年份:2024
- 资助金额:
$ 31.54万 - 项目类别:
Continuing Grant
Elucidation of the mechanism by which actomyosin emerges cell chirality
阐明肌动球蛋白出现细胞手性的机制
- 批准号:
23K14186 - 财政年份:2023
- 资助金额:
$ 31.54万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Deciphering actomyosin contractility regulation during incomplete germ cell division
破译不完全生殖细胞分裂过程中肌动球蛋白收缩性的调节
- 批准号:
573067-2022 - 财政年份:2022
- 资助金额:
$ 31.54万 - 项目类别:
University Undergraduate Student Research Awards
CAREER: Actuating robots with actomyosin active gels
职业:用肌动球蛋白活性凝胶驱动机器人
- 批准号:
2144380 - 财政年份:2022
- 资助金额:
$ 31.54万 - 项目类别:
Continuing Grant
Collaborative Research: Mechanics of Reconstituted Self-Organized Contractile Actomyosin Systems
合作研究:重建自组织收缩肌动球蛋白系统的力学
- 批准号:
2201236 - 财政年份:2022
- 资助金额:
$ 31.54万 - 项目类别:
Standard Grant
Collaborative Research: Mechanics of Reconstituted Self-Organized Contractile Actomyosin Systems
合作研究:重建自组织收缩肌动球蛋白系统的力学
- 批准号:
2201235 - 财政年份:2022
- 资助金额:
$ 31.54万 - 项目类别:
Standard Grant
Coordination of actomyosin and anillo-septin sub-networks of the contractile ring during cytokinesis
胞质分裂过程中收缩环肌动球蛋白和 anillo-septin 子网络的协调
- 批准号:
463633 - 财政年份:2022
- 资助金额:
$ 31.54万 - 项目类别:
Operating Grants
The integrin-dependent B cell actomyosin network drives immune synapse formation and B cell functions
整合素依赖性 B 细胞肌动球蛋白网络驱动免疫突触形成和 B 细胞功能
- 批准号:
546047-2020 - 财政年份:2021
- 资助金额:
$ 31.54万 - 项目类别:
Postdoctoral Fellowships














{{item.name}}会员




